Resources

18 Feb, 2021

The AMR Action Fund announces its first non-industry investment...

Today, the AMR Action Fund announced its first initial close with non-pharmaceutical industry investments of more than US$140 million from...

18 Feb, 2021

The AMR Action Fund announces appointment of CEO, Henry B. Skin...

Dr. Skinner will help ensure the AMR Action Fund achieves its mission to bring two to four new antibiotics to...

4 Dec, 2020

A research and development fund for new treatments for bacteria...

The current focus on the coronavirus disease 2019 (COVID-19) pandemic means a lack of attention to other health challenges, such as antimicrobial resis- tance.

2 Dec, 2020

It's time to fix the antibiotic market...

We need to keep developing new antibiotics to make sure we can keep protecting ourselves from ever-evolving bacteria

2 Dec, 2020

AMR Action Fund Fact Sheet...

The world is losing its most powerful tool in healthcare: antibiotics. The reason is rapidly rising antibiotic-resistant infections – also called antimicrobial resistance, or AMR.

20 Nov, 2020

If Scientists Don't Develop New Antibiotics Soon, 'We'll All Be...

Before joining the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), Duffy served as executive vice president and chief scientific officer at Melinta Therapeutics, a developer of new antibiotics. Despite recently bringing a new antibiotic to market, the company filed for bankruptcy in 2019. It had become one of the increasing number of companies unable to sustain business operations because of the high costs of development coupled with limited revenue potential.

20 Nov, 2020

Biopharmaceutical Representative Joins New Antibiotic Resistanc...

Superbugs that are resistant to existing antibiotics already take an enormous toll on health-care systems around the world.

19 Nov, 2020

Countries brace for ‘silent tsunami’ of antibiotic-resistan...

When drugmaker AstraZeneca closed down its research and development centre in Bangalore six years ago, some of the local scientists managed to find new jobs at a nearby biotech start-up. Since then, they have been working to tackle a problem which is causing concern among doctors in India and around the world: increasing resistance to antibiotics undermining treatments.

18 Nov, 2020

Joint Statement On World Antimicrobial Awareness Week...

The International Society for Quality in Health Care (ISQua), the International Hospital Federation (IHF), the International Alliance of Patients’ Organizations (IAPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) support the Tripartite Organizations.

Loading...
Show More